Skip to content

Diagnosing Minimal Hepatic Encephalopathy

Diagnostik Af Minimal Hepatisk Encephalopati: Association Mellem Kontinuert Reaktionsstidsmåling Og EEG-indices

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05433948
Acronym
MindTheLiver
Enrollment
550
Registered
2022-06-27
Start date
2019-12-01
Completion date
2031-12-01
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Encephalopathy, Liver Cirrhosis

Brief summary

Our purpose is to 1. Examine the correlation between MDF in a resting EEG, recorded just before the CRT test, and the variance in reaction times indicated by the CRT index 2. At simultaneous CRT and EEG recording, examine whether a change in EEG is seen immediately before an extended reaction time occurs (defined by the 75th percentile). This will shed light on a direct pathophysiological association between what is measured with EEG and CRT. 3. Investigate whether cyclicity can be detected in the continuous reaction times and if so, whether amplitude and wavelength in this cyclic activity are correlated to EEG parameters. 4. Examine whether a response to standard HE treatment can be detected with EEG in patients who are thought to suffer from it. As well as if baseline outcome predict future hepatic encephalopathy. 5. With a view to further validating our findings, investigators want to correlate results from EEG and CRT with the most internationally widespread psychometric test, the Portosystemic Encephalopathy test (PSE), which necessitates the establishment of Danish normal values. A secondary purpose of this study is therefore 6. To establish Danish normal values for the PSE test and the Animal Naming test in Danes

Interventions

DIAGNOSTIC_TESTSimultaneous EEG and CRT

EEG is recorded with 32 electrodes and commercial recording equipment.10 min EEG is recorded in idle mode with eyes closed prior to continuous EEG recording during the CRT examination, see below. The test is performed via a laptop using EKHO software. The software generates 150 sound stimuli of 90 dB, which the patient hears in sound-insulated headphones. Via a push button in the dominant hand, the patient must respond as quickly as possible as soon as sounds are perceived. PSE test: Duration 20 min. Includes 5 tasks: Digit-symbol Test, Number Connecting Test A, Number Connecting Test B, Serial Dotting Test and Line Tracing Test. Exits in 4 versions, which are used in repeated tests to avoid the learning effect. Scores range from -18 t0 6 and less -4 is abnormal.

Sponsors

Regionshospitalet Silkeborg
CollaboratorOTHER
Herlev Hospital
CollaboratorOTHER
Aalborg University Hospital
CollaboratorOTHER
Esbjerg Hospital - University Hospital of Southern Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

for patients with liver cirrhosis: 1. Age\> 18 2. Liver cirrhosis verified by biopsy or appropriate clinic and biochemistry as well as imaging. 3. Written informed consent 4. Speaks and understands Danish For the subgroup with liver cirrhosis and normal cognition: 1. Normal result in PSE and CRT testing and clinical examination without evidence of HE For the subgroup with liver cirrhosis and minimal hepatic encephalopathy: 2. Abnormal result in PSE and / or CRT test, but oriented in time, place and own data. For the subgroup with liver cirrhosis and HE grade 2, the following applies: 3. Abnormal PSE and CRT result and / or disoriented in time, place or own data and / or asterixis or other clinical symptoms of HE 4. Ability to collaborate on the performance of CRT test, PSE test and EEG Inclusion criteria healthy: 1. Liver healthy 2. Age over 18 years 3. Formal education ≤ 14 years 4. Written informed consent 5. Speaks and understands Danish Inclusion criteria for pre-cirrhosis liver disease: As for healthy controls plus: 1. In our local outpatient clinic 2. Proven pre-cirrhosis liver disease

Exclusion criteria

1. Organic brain disease (eg previous epilepsy, apoplexy, dementia) 2. Hyponatraemia (Na \<124 mmol / L) 3. Sepsis one week prior to tests. 4. Heart failure (EC less than 30% or NYHA class III and IV) 5. Severe chronic obstructive pulmonary disease (GOLD stage 3 and 4 ie FEV1 / FVC below 0.7 and FEV1 \<50% of expected value) 6. Highly controllable diabetes (HbA1C\> 60 mmol / mol) 7. Renal failure (eGFR below 60) 8. Known neurological diseases (epilepsy, stroke, dementia) 9. Intake of coffee or alcohol 6 hours before tests and change of dose in psychoactive drugs within 6 days of the test (morphine, antipsychotics, antidepressants) -

Design outcomes

Primary

MeasureTime frameDescription
Concordant changes in reaction times and in EEG spectral and frequency analysisUp to 60 monthsDuring CRT 150 reaction times are measured. Investigators want to measure if prolonged reaction times \>75 percentile are preceded by spectral and frequency changes in EEG. For EEG investigators will assess relative theta and delta activity. EEG and CRT will be done simultaneously.
Observation of cyclic activity in continous reaction times (CRT measures)Up to 60 monthsApply mathematically modeled time analysis to establish cyclicity in the 150 measures reaction times and examine if cyclic activity correlates to relative theta and delta activity in the EEG.
Change in EEG spectral and frequency analysis with a clinically indicated standard treatment for minimal hepatic encephalopathyUp to 60 monthsSome patients will be found eligible for treatment with lactulose or rifaximin due to signs of minimal hepatic encephalopathy. Investigators will use EEG relative theta and delta activity to measure the efficacy of the treatment.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026